Status:
COMPLETED
CanMove: A Physical Activity Program for Children With Cancer
Lead Sponsor:
Murdoch Childrens Research Institute
Collaborating Sponsors:
La Trobe University
Conditions:
Pediatric Cancer
Eligibility:
All Genders
5-17 years
Phase:
NA
Brief Summary
This study will evaluate a physical activity intervention for children during acute cancer treatment. The intervention aims to encourage children to participate in increased levels of physical activit...
Detailed Description
All participants will receive the intervention which involves weekly sessions with a physiotherapist and the provision of an activity tracker. The sessions will aim to help motivate participants to be...
Eligibility Criteria
Inclusion
- Is between the ages of 5-17 years at the time of consent
- Diagnosed (or relapsed) with cancer \>4 weeks and \<6 months at time of consent
- Currently receiving cancer treatment at the Royal Children's Hospital
- Has been an in-patient for \>7 consecutive days at the time of consent
- Provide a signed and dated informed consent form and/or has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf
Exclusion
- Deemed by the treating medical team as unsafe to participate
- Child/adolescent unable to mobilise independent of clinical staff assistance, as classified by the research team at the time of consent (use of a gait aid or assistance from a primary carer/support person is accepted). For example, if a child/adolescent requires assistance from nursing staff or physiotherapist in order to walk, they will be excluded.
- Child/adolescent unable to follow simple instructions
- Suitable support person (18 years and over) not available to participate in continuous monitoring of daily steps in tandem with the child/adolescent
- No suitable access to a device to sync with a Fitbit
- Inability or unwillingness of participant or legally acceptable representative to give written informed consent.
Key Trial Info
Start Date :
November 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 3 2021
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04483362
Start Date
November 9 2020
End Date
September 3 2021
Last Update
June 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Children's Hospital
Parkville, Victora, Australia, 3052